☆ 4.6 Letter

Thrombophilia and the risk of post-thrombotic syndrome: retrospective cohort observation

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Journal

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Volume 8, Issue 1, Pages 211-213

Publisher

WILEY

DOI: 10.1111/j.1538-7836.2009.03655.x

Keywords

-

Categories

Hematology Peripheral Vascular Disease

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Review Medicine, General & Internal

Clinical Management of Thrombotic Antiphospholipid Syndrome

Nor Rafeah Tumian, Beverley J. Hunt

Summary: Thrombotic manifestations of antiphospholipid syndrome pose challenges in treatment. This review summarizes the latest literature and guidelines on the management of thrombotic APS, including laboratory assays, the use of direct oral anticoagulants, management of recurrent thrombosis, isolated aPL cases, and catastrophic APS. The goal of treatment is to prevent fatal complications of APS and reduce cardiovascular risks, and this review provides insights and updates on topical issues in APS.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study

Eric Manderstedt, Christina Lind-Hallden, Christer Hallden, Johan Elf, Peter J. Svensson, Bjorn Dahlback, Gunnar Engstrom, Olle Melander, Aris Baras, Luca A. Lotta, Bengt Zoller

Summary: In this study, the thrombotic risk of classic thrombophilias in middle-aged and older adults was investigated. The results showed that disease-causing mutations in the PROC, PROS1, and SERPINC1 genes were associated with venous thromboembolism (VTE). Variants not found in the Human Gene Mutation Database were not linked to VTE. Additionally, heterozygosity for rs6025 and rs1799963 was also associated with an increased risk of VTE. Individuals carrying one classic thrombophilia variant had a higher risk of thrombosis, and the risk was even greater for those with two or more thrombophilia variants.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Add to Collection

Article Hematology

The risk for post-thrombotic syndrome of subjects with deep vein thrombosis in an Indonesian referral hospital: a retrospective cohort study

Farieda Ariyanti, Lugyanti Sukrisman, Dono Antono, Kuntjoro Harimurti

Summary: This retrospective cohort study evaluated the incidence and risk factors of post-thrombotic syndrome (PTS) after 3 months of deep vein thrombosis (DVT) diagnosis. The study found that 53.8% of subjects developed PTS after DVT, with unprovoked DVT and female gender as significant risk factors.

THROMBOSIS JOURNAL (2023)

Add to Collection

Article Gastroenterology & Hepatology

Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study

Ravy K. Vajravelu, Jordan M. Shapiro, Josephine Ni, Shivani U. Thanawala, James D. Lewis, Hashem B. El-Serag

Summary: Individuals concurrently exposed to antibiotics and bowel purgative had slightly higher rates of surrogate IBS outcomes compared with matched controls who did not receive antibiotics concurrently with bowel purgative.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Article Surgery

Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents

Adam M. Gwozdz, Andrew J. Doyle, Beverley J. Hunt, Laura G. Tincknell, Nick Jackson, Prakash Saha, Karen A. Breen, Alberto Smith, Ander Cohen, Stephen A. Black

Summary: The presence of thrombophilia does not affect clinical outcomes after deep venous stenting for post-thrombotic syndrome. Using the same anticoagulation protocol, patients with and without thrombophilia had similar stent patency rates and rates of reinterventions to maintain stent patency. Therefore, thrombophilia should not be a factor in determining eligibility for iliofemoral venous stenting.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2021)

Add to Collection

Review Hematology

Thrombotic risk in children with COVID-19 infection: A systematic review of the literature

Marco Zaffanello, Giorgio Piacentini, Luana Nosetti, Stefania Ganzarolli, Massimo Franchini

Summary: Thrombotic or thromboembolic events are rare in pediatric patients with COVID-19 infection and MIS-C. The most common site of thrombosis is the lung, and heparin is the most frequently used drug. The risk of ischemic stroke in SARS-CoV-2 infection and deep venous thrombosis in MIS-C was lower in children compared to adults.

THROMBOSIS RESEARCH (2021)

Add to Collection

Article Medicine, General & Internal

Patient-Reported Outcomes of Endovascular Treatment of Post-Thrombotic Syndrome: Ancillary Study of a French Cohort

Kevin Guillen, Frederic Thony, Costantino Del Giudice, Gilles Goyault, Arthur David, Frederic Douane, Yann Le Bras, Valerie Monnin-Bares, Jean-Francois Heautot, Herve Rousseau, Thomas Martinelli, Francine Thouveny, Pierre-Antoine Barral, Vincent Le Pennec, Pascal Chabrot, Andre Rogopoulos, Ludwig Serge Aho-Glele, Marc Sapoval, Mathieu Rodiere, Olivier Chevallier, Nicolas Falvo, Romaric Loffroy, V French Soc Cardiovasc Imaging SFIC

Summary: We investigated the differences between patient-reported outcomes and objective criteria in angioplasty/stenting for post-thrombotic syndrome. The results showed that patient-reported outcomes were more consistent and effective in the diagnosis and follow-up of patients with PTS compared to radiologic patency.

DIAGNOSTICS (2023)

Add to Collection

Article Surgery

Prevalence of post-thrombotic syndrome in a cohort of upper extremity vein thrombosis

Henri Herve, Claire Toquet, Gaetan Ploton, Jerome Connault, Giovanni Gautier, Alizee Raimbeau, Guillaume Bergere, Jeanne Hersant, Cecile Durant, Mathieu Artifoni, Nicolas Brebion, Jean-Manuel Kubina, Marc-Antoine Pistorius, Olivier Espitia

Summary: This study aimed to assess the prevalence of post-thrombotic syndrome (PTS) in upper extremity venous thrombosis (UEVT) cases and identify predictive factors of UE-PTS. The results showed that UE-PTS occurred in 14.1% of cases after UEVT, with a history of stroke being a predictive factor. It is suggested that diagnostic criteria should be established for UE-PTS and prospective studies conducted to improve its description and management.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2022)

Add to Collection

Article Clinical Neurology

Risk and cause of death in post-traumatic epilepsy: a register-based retrospective cohort study

Markus Karlander, Johan Ljungqvist, Ann Sorbo, Johan Zelano

Summary: Post-traumatic epilepsy (PTE) is associated with a higher risk of death, and epilepsy seems to contribute to a significant proportion of deaths, especially in younger age groups.

JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Urology & Nephrology

Risk factors of worsening kidney function and mortality in patients with renal vein thrombosis: a retrospective study

Puttinat Wanaratwichit, Chatree Chai-Adisaksopha, Nakarin Inmutto, Kajohnsak Noppakun

Summary: This study aimed to investigate the natural course and outcomes of renal vein thrombosis. The findings showed that renal vein thrombosis is associated with worsening kidney function and increased mortality rate. Prompt identification and early treatment of high-risk patients are crucial for preventing adverse outcomes.

JOURNAL OF NEPHROLOGY (2023)

Add to Collection

Review Virology

New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination

Qiqi Ma, Gaosi Xu

Summary: Thrombotic microangiopathy (TMA) associated with COVID-19 vaccination, particularly mRNA vaccines, is characterized by different clinical presentations such as thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS). Females tend to develop TTP symptoms after the first vaccine dose, while males are more likely to experience them after the second dose. TTP patients commonly receive plasma exchange (PEX)-based treatment, whereas aHUS patients often undergo non-PEX therapies.

JOURNAL OF MEDICAL VIROLOGY (2023)

Add to Collection

Article Clinical Neurology

Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations

Zeev Meiner, Emmeline Ayers, David A. Bennett, Cuiling Wang, Joe Verghese

Summary: Motoric cognitive risk syndrome (MCR) is a predementia syndrome characterized by cognitive complaints and slow gait. Research found that depressive symptoms and other specific factors can predict the transition to dementia in individuals with MCR. This suggests common pathological mechanisms underlying mood, gait and cognitive declines in aging, which could aid in developing preventive strategies.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Surgery

Predictors for the risk and severity of post-thrombotic syndrome in vascular Behcet's disease

Aysun Aksoy, Seda Colak, Burcu Yagiz, Belkis Nihan Coskun, Ahmet Omma, Yasin Yildiz, Alper Sari, Nuh Atas, Can Ilgin, Omer Karadag, Abdulsamet Erden, Ediz Dalkilic, Naile Bolca, Rabia Ergelen, Mehmet Ruhi Onur, Haner Direskeneli, Fatma Alibaz-Oner

Summary: The study found that patients with BD and accompanying DVT have a high risk of developing severe PTS, immunosuppressive therapy can reduce the occurrence of severe PTS, AC therapy may influence the course of PTS by increasing collateral scores, and the use of interferon-α is beneficial for recanalization scores. Routine Doppler US examination may help predict the development of severe PTS.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS (2021)

Add to Collection

Article Clinical Neurology

Statin Treatment in the Acute Phase and the Risk of Post-stroke Pneumonia: A Retrospective Cohort Study

Changling Li, Mengmeng Ma, Shuju Dong, Ye Hong, Jiajia Bao, Yang Zhang, Lijie Gao, Chaohua Cui, Jian Guo, Li He

Summary: The study found that there were no additional benefits of statin treatment in the acute phase for reducing post-stroke pneumonia among AIS patients. Statin treatment did not significantly increase the risk or severity of post-stroke pneumonia.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Article Immunology

Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy

Idris Boudhabhay, Marion Rabant, Lubka T. Roumenina, Louis-Marie Coupry, Victoria Poillerat, Armance Marchal, Veronique Fremeaux-Bacchi, Khalil El Karoui, Mehran Monchi, Franck Pourcine

Summary: This case report describes a 46-year-old male patient with post-COVID-19 MIS-A, who showed significant improvement in renal function after specific complement inhibition treatment, indicating that TMA may play a crucial role in the pathophysiology of post-COVID-19 MIS-A.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Peripheral Vascular Disease

Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants

Luca Spiezia, Elena Campello, Chiara Simion, Anna Poretto, Fabio Dalla Valle, Paolo Simioni

Summary: The incidence of post-thrombotic syndrome (PTS) in patients with deep vein thrombosis (DVT) treated with direct oral anticoagulants (DOACs) remains significant, and obesity and iliofemoral DVT may be predisposing risk factors for PTS.

ANGIOLOGY (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Letter to the editor: Is PAI-1 a thrombotic biomarker in NASH cirrhosis?

Alberto Zanetto, Elena Campello, Luca Spiezia, Patrizia Burra, Paolo Simioni, Marco Senzolo

HEPATOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Haemostatic alterations in patients with cirrhosis and hepatocellular carcinoma: laboratory evidence and clinical implications

Alberto Zanetto, Elena Campello, Filippo Pelizzaro, Fabio Farinati, Patrizia Burra, Paolo Simioni, Marco Senzolo

Summary: Venous thrombosis is a common complication in cancer, Hepatocellular carcinoma (HCC) is the most common primary liver cancer. It is associated with preexisting cirrhosis in 90% of cases. Patients with cirrhosis are more prone to bleed or thrombotic complications. There is evidence that HCC may increase the risk of venous thrombosis in cirrhosis patients. However, there are currently no specific guidelines for risk stratification and management of thromboprophylaxis in patients with cirrhosis and HCC.

LIVER INTERNATIONAL (2022)

Add to Collection

Article Hematology

Mechanisms of thrombosis in pancreatic ductal adenocarcinoma

Elena Campello, Floris Bosh, Chiara Simion, Luca Spiezia, Paolo Simioni

Summary: This review summarizes the epidemiology and pathogenesis of thrombotic complications in patients with pancreatic cancer, and introduces novel mechanisms of hypercoagulability such as neutrophil extracellular traps and extracellular vesicles. The article also discusses the important role of these mechanisms in platelet and coagulation activation.

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2022)

Add to Collection

Article Hematology

Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study

Elena Campello, Cristiana Bulato, Chiara Simion, Luca Spiezia, Claudia Maria Radu, Sabrina Gavasso, Francesca Sartorello, Graziella Saggiorato, Patrizia Zerbinati, Mariangela Fadin, Daniela Tormene, Paolo Simioni

Summary: This study longitudinally evaluated coagulation profiles in healthy subjects who received COVID-19 vaccination and found that although there was a slight increase in thrombin generation in some subjects after vaccination, there was no clinically significant hypercoagulability. Platelet count, aggregation, and thromboelastometry parameters did not show relevant differences. No thrombotic or hemorrhagic events occurred.

THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Virology

Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation

Francesco Poletto, Luca Spiezia, Chiara Simion, Elena Campello, Fabio Dalla Valle, Daniela Tormene, Giuseppe Camporese, Paolo Simioni

Summary: Obesity and bilateral pulmonary infiltrates on imaging may be risk factors for in-hospital venous thromboembolism in patients with acute COVID-19 pneumonia. Prophylactic-dose heparin may not be sufficient in preventing VTE episodes.

VIRUSES-BASEL (2022)

Add to Collection

Letter Medicine, General & Internal

POST-discharge thromboprophylaxis in patients with COVID-19: a single-center experience

Chiara Simion, Elena Campello, Andrea Boccatonda, Daniela Tormene, Luca Spiezia, Fabio Dalla Valle, Marta Sartori, Nicola Perin, Chiara Forestan, Paolo Simioni

INTERNAL AND EMERGENCY MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study

Filippo Catalani, Elena Campello, Giuseppina Occhipinti, Alessandro Zorzi, Marta Sartori, Bruno Micael Zanforlini, Alessandro Franchin, Paolo Simioni, Giuseppe Sergi

Summary: Direct oral anticoagulants (DOACs) are underused in the elderly population, despite the evidence supporting their use. In this study, anticoagulant-naive patients aged 75 years and above were prospectively enrolled and stratified into older adults (aged 75-84 years) and extremely older adults (85 years and above). The results showed that extremely older adults had a higher incidence of thrombotic and hemorrhagic events compared to older adults in the first year of DOAC therapy. Several factors were associated with an increased risk of these events in both age groups.

INTERNAL AND EMERGENCY MEDICINE (2023)

Add to Collection

Article Medicine, General & Internal

Persistently High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis

Luca Spiezia, Chiara Forestan, Elena Campello, Chiara Simion, Paolo Simioni

Summary: This case-control study aimed to identify the effect of persistently increased plasma FXI levels on the risk of deep vein thrombosis (DVT). The study found that elevated FXI levels constitute a risk factor for DVT, and this risk nearly doubled in patients with persistently increased FXI levels.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Review Medicine, General & Internal

Thromboembolic and Bleeding Events in Transthyretin Amyloidosis and Coagulation System Abnormalities: A Review

Angela Napolitano, Laura De Michieli, Giulio Sinigiani, Tamara Berno, Alberto Cipriani, Luca Spiezia

Summary: Transthyretin amyloidosis (ATTR) is a group of diseases caused by insoluble fibril deposition from misfolded transthyretin. It affects various organs, including the heart. Thromboembolic events and increased bleeding risk are important complications of ATTR, but their underlying mechanisms are not fully understood.

JOURNAL OF CLINICAL MEDICINE (2023)

Add to Collection

Article Chemistry, Medicinal

1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2

Monica Chinellato, Matteo Gasparotto, Santina Quarta, Mariagrazia Ruvoletto, Alessandra Biasiolo, Francesco Filippini, Luca Spiezia, Laura Cendron, Patrizia Pontisso

Summary: In recent years, studies on the inflammatory signaling pathways have identified new targets for novel therapies. This research reveals that the small molecule 1-PPA can bind to PAR2 and exhibit antagonistic effects on its activity, potentially providing a promising new approach for the treatment of PAR2-related diseases.

PHARMACEUTICALS (2023)

Add to Collection

Article Gastroenterology & Hepatology

Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections

Alberto Zanetto, Elena Campello, Cristiana Bulato, Sabrina Gavasso, Graziella Saggiorato, Sarah Shalaby, Patrizia Burra, Paolo Angeli, Marco Senzolo, Paolo Simioni

Summary: Bacterial infections in patients with decompensated cirrhosis are associated with reduced platelet aggregation and decreased levels of natural anticoagulants, potentially increasing the risk of bleeding and thrombosis.

JHEP REPORTS (2022)

Add to Collection

Article Hematology

Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow

Sanne L. N. Brouns, Bibian M. E. Tullemans, Cristiana Bulato, Gina Perrella, Elena Campello, Luca Spiezia, Johanna P. van Geffen, Marijke J. E. Kuijpers, Rene van Oerle, Henri M. H. Spronk, Paola E. J. van der Meijden, Paolo Simioni, Johan W. M. Heemskerk

Summary: This study assessed the role of platelets in thrombus and fibrin formation in patients with protein C or protein S deficiency under high-shear flow conditions. The results showed that these patients had impaired platelet activation, thrombus phenotype, and fibrin formation, but unchanged platelet adhesion. The defect may be caused by negative platelet priming.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.